Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 5;10(11):e043634.
doi: 10.1136/bmjopen-2020-043634.

Ensuring that COVID-19 research is inclusive: guidance from the NIHR INCLUDE project

Affiliations
Review

Ensuring that COVID-19 research is inclusive: guidance from the NIHR INCLUDE project

Miles D Witham et al. BMJ Open. .

Abstract

Objective: To provide guidance to researchers, funders, regulators and study delivery teams to ensure that research on COVID-19 is inclusive, particularly of groups disproportionately affected by COVID-19 and who may have been historically under-served by research.

Summary of key points: Groups who are disproportionately affected by COVID-19 include (but are not limited to) older people, people with multiple long-term conditions, people with disabilities, people from Black, Asian and Ethnic minority groups, people living with obesity, people who are socioeconomically deprived and people living in care homes. All these groups are under-served by clinical research, and there is an urgent need to rectify this if COVID-19 research is to deliver relevant evidence for these groups who are most in need. We provide a framework and checklists for addressing key issues when designing and delivering inclusive COVID-19 research, based on the National Institute for Health Research INnovations in CLinical trial design and delivery for the UnDEr-served project roadmap. Strong community engagement, codevelopment and prioritisation of research questions and interventions are essential. Under-served groups should be represented on funding panels and ethics committees, who should insist on the removal of barriers to participation. Exclusion criteria should be kept to a minimum; intervention delivery and outcome measurement should be simple, flexible and tailored to the needs of different groups, and local advice on the best way to reach and engage with under-served communities should be taken by study delivery teams. Data on characteristics that allow identification of under-served groups must be collected, analyses should include these data to enable subgroup comparisons and results should be shared with under-served groups at an early stage.

Conclusion: Inclusive COVID-19 research is a necessity, not a luxury, if research is to benefit all the communities it seeks to serve. It requires close engagement with under-served groups and attention to aspects of study topic, design, delivery, analysis and dissemination across the research life cycle.

Keywords: COVID-19; public health; statistics & research methods.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
The INCLUDE roadmap (reproduced from National Institute for Health Research [6] under a creative commons attribution 4.0 international license).

References

    1. Ramanan M, Stolz A, Rooplalsingh R, et al. . An evaluation of the quality and impact of the global research response to the COVID-19 pandemic. Med J Aust 2020;213:380. 10.5694/mja2.50790 - DOI - PMC - PubMed
    1. International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) consortium COVID-19 report April 27th 2020. Available: https://media.tghn.org/medialibrary/2020/05/ISARIC_Data_Platform_COVID19...[Accessed 11 Aug 2020].
    1. Williamson EJ, Walker AJ, Bhaskaran K, et al. . OpenSAFELY: factors associated with COVID-19 death in 17 million patients. Nature 2020;584:430–6. - PMC - PubMed
    1. Crome P, Lally F, Cherubini A, et al. . Exclusion of older people from clinical trials: professional views from nine European countries participating in the predict study. Drugs Aging 2011;28:667–77. 10.2165/11591990-000000000-00000 - DOI - PubMed
    1. Treweek S, Forouhi NG, Narayan KMV, et al. . COVID-19 and ethnicity: who will research results apply to? Lancet 2020;395:1955–7. 10.1016/S0140-6736(20)31380-5 - DOI - PMC - PubMed

Publication types